Suppr超能文献

抗菌药物敏感性试验对ISO 20776标准的适应性及方法验证

Adaptation of Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.

作者信息

Tscherne Alina, Mantel Enrico, Boskani Talar, Budniak Sylwia, Elschner Mandy, Fasanella Antonio, Feruglio Siri L, Galante Domenico, Giske Christian G, Grunow Roland, Henczko Judit, Hinz Christin, Iwaniak Wojciech, Jacob Daniela, Kedrak-Jablonska Agnieszka, Jensen Veronica K, Johansen Tone B, Kahlmeter Gunnar, Manzulli Viviana, Matuschek Erika, Melzer Falk, Nuncio Maria S, Papaparaskevas Joseph, Pelerito Ana, Solheim Margrete, Thomann Susanne, Tsakris Athanasios, Wahab Tara, Weiner Marcin, Zoeller Lothar, Zange Sabine

机构信息

Bundeswehr Institute of Microbiology, Neuherbergstrasse 11, 80937 Munich, Germany.

Division of Virology, Department of Veterinary Sciences, LMU Munich, Veterinärstrasse 13, 80539 Munich, Germany.

出版信息

Microorganisms. 2022 Jul 20;10(7):1470. doi: 10.3390/microorganisms10071470.

Abstract

Brucellosis, mainly caused by (B.) , is associated with a risk of chronification and relapses. Antimicrobial susceptibility testing (AST) standards for are not available, and the agent is not yet listed in the EUCAST breakpoint tables. CLSI recommendations for exist, but they do not fulfill the requirements of the ISO 20776 standard regarding the culture medium and the incubation conditions. Under the third EU Health Programme, laboratories specializing in the diagnostics of highly pathogenic bacteria in their respective countries formed a working group within a Joint Action aiming to develop a suitable method for the AST of . Under the supervision of EUCAST representatives, this working group adapted the CLSI M45 document to the ISO 20776 standard after testing and validation. These adaptations included the comparison of various culture media, culture conditions and AST methods. A Standard Operation Procedure was derived and an interlaboratory validation was performed in order to evaluate the method. The results showed pros and cons for both of the two methods but also indicate that it is not necessary to abandon Mueller-Hinton without additives for the AST of .

摘要

布鲁氏菌病主要由(布鲁氏菌属)引起,存在慢性化和复发风险。针对布鲁氏菌属的抗菌药物敏感性试验(AST)标准尚不存在,且该病原体尚未列入欧洲抗菌药物敏感性试验委员会(EUCAST)的折点表中。美国临床和实验室标准协会(CLSI)有关于布鲁氏菌属的建议,但不符合ISO 20776标准中关于培养基和培养条件的要求。在第三个欧盟卫生计划下,各国专门从事高致病性细菌诊断的实验室在一项联合行动中成立了一个工作组,旨在开发一种适用于布鲁氏菌属AST的方法。在EUCAST代表的监督下,该工作组在测试和验证后将CLSI M45文件调整为符合ISO 20776标准。这些调整包括比较各种培养基、培养条件和AST方法。得出了一份标准操作程序,并进行了实验室间验证以评估该方法。结果显示两种方法都有优缺点,但也表明在布鲁氏菌属的AST中没有必要摒弃不含添加剂的穆勒-欣顿培养基。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902c/9316112/c74b196d1ded/microorganisms-10-01470-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验